(Q47336896)
Statements
Association between the PPARalpha L162V polymorphism, plasma lipoprotein levels, and atherosclerotic disease in patients with diabetes mellitus type 2 and in nondiabetic controls (English)
Ioanna Gouni-Berthold
Eleni Giannakidou
Dirk Müller-Wieland
Michael Faust